BioMed Research International / 2017 / Article / Tab 3

Research Article

Prognostic Significance of Blood Transfusion in Newly Diagnosed Multiple Myeloma Patients without Autologous Hematopoietic Stem Cell Transplantation

Table 3

Multivariate analysis of the correlation between demographic and clinicopathological characteristics and survival time in patients with MM.

Covariates Overall survival Progression-free survival
95% CI for HR95% CI for HR

Age1.005–1.0380.011N/AN/A
Ig isotypeN/AN/A0.659–0.9570.015
ISS staging0.697–1.6610.7400.694–1.6480.761
Plt (×109/L)0.369–0.9390.0260.409–1.0840.102
Scr (μmol/L)0.977–2.4530.0630.975–2.5010.063
-MG (μmol/L)0.665–2.5240.4470.849–3.2440.138
Ca (mmol/L)1.172–3.3890.0110.838–2.2790.205
Thalidomide0.277–0.6120.0000.286–0.6410.000
Blood transfusionN/AN/A0.735–1.4530.849

ISS: International Staging System; Scr: serum creatinine; β2-MG: β2-microglobulin; Ca: calcium; HR: hazard ratio; CI: confidence interval; N/A: not available.